Inventor · disambiguated record
Marc Schiller
Also filed as: SCHILLER MARC · SCHILLER MARC I
7 granted patents·15 pending applications·19 citations·filing 2004–2025
79Inventor score
Top patents by PatentIndex Score
22 records- 0185US10912763B2Pharmaceutical dosage forms comprising 6′-fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amineGRUENENTHAL GMBH·Filed 2016·Granted Feb 9, 2021·4 cites·17 claims
- 0284US9446008B2Semisolid aqueous pharmaceutical composition containing tapentadolREINHOLD ULRICH·Filed 2012·Granted Sep 20, 2016·10 cites·14 claims
- 0378US9289416B2Pharmaceutical dosage forms comprising 6′-fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amineGRUENENTHAL GMBH·Filed 2014·Granted Mar 22, 2016·5 cites·30 claims
- 0471US11547678B2Aqueous pharmaceutical formulation of tapentadol for oral administrationGRUENENTHAL GMBH·Filed 2019·Granted Jan 10, 2023·0 cites·13 claims
- 0570US2025295596A1Multiparticulate oral dosage form providing prolonged release of tapentadolGRUENENTHAL GMBH·Filed 2024·Application pending·0 cites
- 0663US2025228775A1Ethanolic resiniferatoxin concentrateGRUENENTHAL GMBH·Filed 2025·Application pending·0 cites
- 0761US2020215003A1Parenteral administration of tapentadolGRUENENTHAL GMBH·Filed 2020·Application pending·0 cites
- 0859US2018133174A1Semisolid Aqueous Pharmaceutical Composition Containing TapentadolGRUENENTHAL GMBH·Filed 2018·Application pending·0 cites
- 0955US2016346229A1Semisolid Aqueous Pharmaceutical Composition Containing TapentadolGRUENENTHAL GMBH·Filed 2016·Application pending·0 cites
- 1051US8703192B2Dosage form containing pantoprazole as active ingredientANSTETT-KLEIN ISABEL·Filed 2009·Granted Apr 22, 2014·0 cites·9 claims
- 1149US2013022670A1Aqueous Pharmaceutical Formulation of Tapentadol for Oral AdministrationGRUENENTHAL GMBH·Filed 2012·Application pending·0 cites
- 1246US11013701B2Stable formulation for parenteral administration of tapentadolGRUENENTHAL GMBH·Filed 2018·Granted May 25, 2021·0 cites·22 claims
- 1346US2016220516A1Aqueous Pharmaceutical Formulation of Tapentadol for Oral AdministrationGRUENENTHAL GMBH·Filed 2016·Application pending·0 cites
- 1446US2016106688A1Parenteral Administration of TapentadolGRUENENTHAL GMBH·Filed 2015·Application pending·0 cites
- 1544US8758817B2Dosage form containing (S)-pantoprazole as active ingredientDIETRICH RANGO·Filed 2011·Granted Jun 24, 2014·0 cites·11 claims
- 1644US2016279078A1Stable Formulation for Parenteral Administration of TapentadolGRUENENTHAL GMBH·Filed 2016·Application pending·0 cites
- 1743US2012034297A1Pharmaceutical dosage forms comprising 6'-fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amineGRUENING NADJA·Filed 2011·Application pending·0 cites
- 1843US2006216346A1Dosage form containing (s)-pantoprazole as active ingredientALTANA PHARMA·Filed 2004·Application pending·0 cites
- 1943US2018369151A1Multiparticulate oral dosage form providing prolonged release of tapentadolGRUENENTHAL GMBH·Filed 2018·Application pending·0 cites
- 2043US2009183633A1Filter comb apparatus and methodSCHILLER MARC I·Filed 2007·Application pending·0 cites
- 2142US2012156632A1Method and apparatus for dental deviceSCHILLER MARC I·Filed 2010·Application pending·0 cites
- 2233US2007231388A1Novel Pharmaceutical Dosage Form and Manufacturing ProcessATLANA PHARMA AG·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →